A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.
The Epstein-Barr virus and a high-risk gene may work together to trick the immune system into attacking the brain in MS, a ...
In July 2025, a class 2 resubmission of tab-cel’s BLA was initiated by Atara Biotherapeutics, developer and sponsor of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results